AddGraft Therapeutics has developed a revolutionary gene delivery platform that, through a onetime treatment, will effectively cure substance abuse disorder. AddGraft’s treatment is long lasting, minimally invasive and unlike other treatments, has very low toxicity and is easy for patients to use and adhere to.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Chicago, Il, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Chicago, IL
Addgraft Therapeutics Questions
Addgraft Therapeutics's website is https://www.addgrafttherapeutics.com/
Addgraft Therapeutics's LinkedIn profile is https://www.linkedin.com/company/addgraft-therapeutics
Addgraft Therapeutics has
1 employees.
View email and phone details for 1
employees at Addgraft Therapeutics.
Addgraft Therapeutics's industry is
Biotechnology Research
Addgraft Therapeutics's top competitors are
Patrin Pharma, Inc.,
Alnair Therapeutics,
Prunus Therapeutics,
Seurat Therapeutics, Inc,
Oxalo Therapeutics, Inc.,
Acura Pharmaceuticals, Inc,
Chicago Research Center, Inc,
Tract Therapeutics, Inc.,
Siwa Therapeutics,
Elorac, Inc.
Addgraft Therapeutics's categories are Biotechnology Research
Addgraft Therapeutics's founding year is 2021
